Key facts
- It has raised $200K; the latest was Seed Round in Sep 2025.
- Notable investors include Enterprise Ireland, EIT Food, Big Idea Ventures, AgTechUCD Innovation Centre, Circuléire — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Niskus
- ·The full record, as it builds
Funding rounds
No funding rounds for Niskus are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Niskus
Operator of a biotechnology firm intended to produce sustainable food ingredients. The company integrates bespoke microbial fermentation processes, modular and mobile units for on-site conversion of liquid and solid side streams, food-grade fungal strains, enzymatic treatments, and scalable production methods, enabling biotech companies to transform waste streams into protein-rich, functional ingredients for food, feed, nutraceutical, enzymes, and biomaterials in an environmentally sustainable, economically viable, and circular manner.
- Sector
- Business Products and Services (B2B)
- HQ
- Donegal, Ireland
- Founded
- 2021
- Employees
- 3
- Website
- niskusbiotec.com/
- Ownership
- Privately Held (backing)
Niskus doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Niskus shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Niskus in its N-PORT filings yet. We sweep new filings monthly.